Gentest® Research Services’ in vitro reaction phenotyping studies cover a comprehensive portfolio of phase-I and phase-II drug metabolizing enzymes, elucidating the metabolic pathway of new chemical entities (NCEs) and identifying vulnerabilities to drug-drug interactions.
Gentest® has been providing expert, regulatory submission-quality ADME services for more than two decades. Our experts use high-performance Gentest® reagents and regulatory guidance-driven protocols to ensure reliable, meaningful results.
